ORIC ORIC Pharmaceuticals, Inc.
Healthcare$8.32-1.65%ClosedMarket Cap: $861.3M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$20.40
Target (Median)
$22.00
Target Range
$15.00 - $25.00
Upside from current price: 145.2%
Rating Distribution
2 Strong Buy13 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-05 | Citigroup | maintain | Buy | Buy |
| 2026-04-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-01 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-24 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-24 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-24 | Citigroup | maintain | Buy | Buy |
| 2026-01-13 | Wedbush | maintain | Outperform | Outperform |
| 2025-12-08 | Wedbush | maintain | Outperform | Outperform |
| 2025-12-08 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-11-18 | JP Morgan | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.54 | $2.2M | 9 |
| Sun Dec 31 | $-1.62 | $10.8M | 6 |
| Mon Dec 31 | $-1.75 | $73.2M | 4 |
| Tue Dec 31 | $-0.44 | $259.3M | 2 |